The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies;Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta-análise de estudos observacionais

Revista Portuguesa de Cardiologia

Volumn 33, Issue 9, 2014, Pages 555-560

  Caldeira, Daniel ^a,b   Barra, Márcio ^a,b   David, Cláudio ^a,b,c   Costa, João ^a,b   Ferreira, Joaquim J ^a,b   Pinto, Fausto J ^c  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Anticoagulation; Atrial fibrillation; Coumarins; Prevalence; Vitamin K antagonistsThe; Warfarin

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; COMMUNITY; HEART ATRIUM FIBRILLATION; HOSPITAL; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PORTUGAL; PRACTICE GUIDELINE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ATRIAL FIBRILLATION; COMPLICATION; ORAL DRUG ADMINISTRATION; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; PORTUGAL; THROMBOEMBOLISM;

EID: 84908158900     PISSN: 08702551     EISSN: 21742030     Source Type: Journal    
DOI: 10.1016/j.repc.2014.02.014     Document Type: Short Survey

References (34)

1. D. Bonhorst, M. Mendes, and P. Adragão Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study Rev Port Cardiol 29 2010 331 350
2. G.Y. Lip, D.J. Golding, and M. Nazir A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project Br J Gen Pract 47 1997 285 289
3. G.V. Naccarelli, H. Varker, and J. Lin Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 2009 1534 1539
4. A.J. Camm, P. Kirchhof, G.Y. Lip European Heart Rhythm Association European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
5. M.H. Boyle Guidelines for evaluating prevalence studies Evid Based Ment Health 1 1998 37 39
6. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
7. J.J. Deeks, D.G. Altman, and M.J. Bradburn M. Egger, G. Davey Smith, D.G. Altman, Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic reviews in health care: meta-analysis in context 2 nd ed. 2001 BMJ Publication Group London 313 335
8. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 [acedido Set 2013]. Disponível em: www.cochrane-handbook.org
9. P. Ascenção Fibrilhação auricular e prevenção do tromboembolismo Estudo numa população de utentes de Centros de Saúde Rev Port Clin Geral 22 2006 13 24
10. P. Reis, T. Patrícia, and L. Dutschmann Fibrilhação auricular: das guidelines à realidade Med Interna 13 2006 155 161
11. H. Dores, R. Cardiga, and R. Ferreira Atrial fibrillation and thromboembolic risk: what is the extent of adherence to guidelines in clinical practice? Rev Port Cardiol 30 2011 171 180
12. E. Jorge, F.S. Pereira, and R. Baptista Anticoagulation in elderly patients with atrial fibrillation: from the guidelines to the daily medical practice Acta Med Port 24 2011 293 300
13. M.C. Sá, and M.J. Balsa Anticoagulação oral nos muito idosos e seus determinantes clínicos Rev Port Med Geral Fam 28 2012 168 176
14. T. Pereira-Da-Silva, T. Souto Moura, and L. Azevedo Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants Acta Med Port 26 2013 127 132
15. Portugal - Doença cerebro-cardiovasculares em números - 2013; Direcção Geral da Saúde.[consultado Nov 2013]. Disponível em: http://www.spc.pt/DL/Home/fm/i019350.pdf
16. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
17. H.J. Lin, P.A. Wolf, and M. Kelly-Hayes Stroke severity in atrial fibrillation. The Framingham Study Stroke 27 1996 1760 1764
18. D.A. Dulli, H. Stanko, and R.L. Levine Atrial fibrillation is associated with severe acute ischemic stroke Neuroepidemiology 22 2003 118 123
19. P.A. Wolf, J.B. Mitchell, and C.S. Baker Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
20. O. Ghatnekar, and E.L. Glader The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001 Value Health 11 2008 862 868
21. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
22. M. Zoni-Berisso, A. Filippi, and M. Landolina Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study) Am J Cardiol 111 2013 705 711
23. M. Volterrani, F. Iellamo, and G. Rosano Anticoagulation in «real world» patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study Int J Cardiol 168 2013 4729 4733
24. A.K. Kakkar, I. Mueller, and J.P. Bassand Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry PLoS One 8 2013 e63479
25. T. Meinertz, W. Kirch, and L. Rosin Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry Clin Res Cardiol 100 2011 897 905
26. P. Kirchhof, B. Ammentorp, and H. Darius Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) Europace 2013 PubMed PMID: 24084680
27. S.J. Connolly, J. Eikelboom, and C. Joyner Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
28. B.L. Limone, W.L. Baker, and J. Kluger Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models PLoS One 8 2013 e62183
29. W.J. Canestaro, A.R. Patrick, and J. Avorn Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation Circ Cardiovasc Qual Outcomes 6 2013 724 731
30. A.J. Camm, G.Y. Lip, and R. de Caterina 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
31. T.B. Larsen, G.Y. Lip, and F. Skjøth Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet Cancer, and Health cohort study Circ Cardiovasc Qual Outcomes 5 2012 335 342
32. V. Fuster, L.E. Rydén, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745
33. H.J. Chang, J.R. Bell, and D.B. Deroo Physician variation in anticoagulating patients with atrial fibrillation Dartmouth Primary Care COOP Project Arch Intern Med 150 1990 83 86
34. J. Mant, F.D. Hobbs, and K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study BAFTA): a randomised controlled trial Lancet 370 2007 493 503